Hematopoietic Innovative Therapies

“CIEMAT’s Hematopoietic Innovative Therapies group is  focused on the development of translational research to improve the diagnosis and treatment of inherited and acquired pathologies through genetic, molecual and cellular biology techniques”

 

Scientist Spotlight: Paula Rio

31/10/2019 Scientist Spotlight: Paula Rio

La fundación para la investigación en Anemia de Fanconi entrevista a la Dra. Paula Rio por su amplia experiencia en la investigación en esta enfermedad.

  • Foto1
  • Foto2
  • Foto3
  • Foto4
News Highlights

Fanconi Anemia

A gene therapy clinical trial for patients with Fanconi Anemia offers its first successful results

Dyskeratosis Congenita

A new cell model of dyskeratosis congenita will help understand the disease and evaluate new therapies

LAD-I immunodeficiency

First successful results in gene therapy in a patient with LAD-I immunodeficiency

 

 

Logo CIEMAT Portal web grupo Terapias Innovadoras Información útil | Congresos Portal web UE - Desarrollo Regional Portal web Instituto de Investigación Sanitaria